Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

63 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Coupling of a Major Allergen to the Surface of Immune Cells for Use in Prophylactic Cell Therapy for the Prevention of IgE-Mediated Allergy.
Mengrelis K, Niederacher G, Prickler L, Kainz V, Weijler AM, Rudolph E, Stanek V, Eckl-Dorna J, Baranyi U, Spittler A, Focke-Tejkl M, Bohle B, Valenta R, Becker CFW, Wekerle T, Linhart B. Mengrelis K, et al. Among authors: linhart b. Cells. 2024 Mar 3;13(5):446. doi: 10.3390/cells13050446. Cells. 2024. PMID: 38474409 Free PMC article.
Vaccines for allergy.
Linhart B, Valenta R. Linhart B, et al. Curr Opin Immunol. 2012 Jun;24(3):354-60. doi: 10.1016/j.coi.2012.03.006. Epub 2012 Apr 20. Curr Opin Immunol. 2012. PMID: 22521141 Free PMC article. Review.
Cell Therapy for Prophylactic Tolerance in Immunoglobulin E-mediated Allergy.
Baranyi U, Farkas AM, Hock K, Mahr B, Linhart B, Gattringer M, Focke-Tejkl M, Petersen A, Wrba F, Rülicke T, Valenta R, Wekerle T. Baranyi U, et al. Among authors: linhart b. EBioMedicine. 2016 May;7:230-9. doi: 10.1016/j.ebiom.2016.03.028. Epub 2016 Mar 20. EBioMedicine. 2016. PMID: 27322476 Free PMC article.
Adoptive transfer of allergen-expressing B cells prevents IgE-mediated allergy.
Prickler L, Baranyi U, Mengrelis K, Weijler AM, Kainz V, Kratzer B, Steiner R, Mucha J, Rudoph E, Pilat N, Bohle B, Strobl H, Pickl WF, Valenta R, Linhart B, Wekerle T. Prickler L, et al. Among authors: linhart b. Front Immunol. 2023 Nov 23;14:1286638. doi: 10.3389/fimmu.2023.1286638. eCollection 2023. Front Immunol. 2023. PMID: 38077381 Free PMC article.
Vaccine engineering improved by hybrid technology.
Linhart B, Valenta R. Linhart B, et al. Int Arch Allergy Immunol. 2004 Aug;134(4):324-31. doi: 10.1159/000079535. Epub 2004 Jul 2. Int Arch Allergy Immunol. 2004. PMID: 15240999 Review.
Molecular design of allergy vaccines.
Linhart B, Valenta R. Linhart B, et al. Curr Opin Immunol. 2005 Dec;17(6):646-55. doi: 10.1016/j.coi.2005.09.010. Epub 2005 Oct 17. Curr Opin Immunol. 2005. PMID: 16229996 Review.
A combination vaccine for allergy and rhinovirus infections based on rhinovirus-derived surface protein VP1 and a nonallergenic peptide of the major timothy grass pollen allergen Phl p 1.
Edlmayr J, Niespodziana K, Linhart B, Focke-Tejkl M, Westritschnig K, Scheiblhofer S, Stoecklinger A, Kneidinger M, Valent P, Campana R, Thalhamer J, Popow-Kraupp T, Valenta R. Edlmayr J, et al. Among authors: linhart b. J Immunol. 2009 May 15;182(10):6298-306. doi: 10.4049/jimmunol.0713622. J Immunol. 2009. PMID: 19414783
From allergen genes to allergy vaccines.
Valenta R, Ferreira F, Focke-Tejkl M, Linhart B, Niederberger V, Swoboda I, Vrtala S. Valenta R, et al. Among authors: linhart b. Annu Rev Immunol. 2010;28:211-41. doi: 10.1146/annurev-immunol-030409-101218. Annu Rev Immunol. 2010. PMID: 20192803 Review.
63 results